EUVIMEDEUVIMED entdecken
Crossref

Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the Janus Kinase 2 and Signal Transducer and Activator of Transcription 3 Signaling Pathway

ZhengHu Xu, Wei Liu, Huai Huang

Pharmacology · 2020 · 105 (3-4) · 181-189

DOI: 10.1159/000503361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology, online erschienen am 11.12.2019. Verfasst von ZhengHu Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Chinese National Petroleum Corporation Central Hospital, Langfang, China. Die Arbeit wurde bisher 25-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astragaloside IV (AS-IV) is an active component extracted from the traditional Chinese herbal medicine. AS-IV is a neuroprotective component in cerebral ischemic models. However, roles of AS-IV in cerebral ischemia-reperfusion (I/R) injury and the underlying mechanisms are rarely investigated. The role of AS-IV in oxygen – glucose deprivation reoxygenation (OGD/R)-induced cell proliferation and apoptosis assays were analyzed by Cell Counting Kit-8 and Flow cytometric. Western Blot assays were performed to measure the related expression levels in SH-SY5Y cells. Meanwhile, activities of reactive oxygen species (ROS), superoxide dismutase (SOD), and malondialdehyde (MDA) in OGD/R-induced cells were determined by relative commercial kits. AS-IV was also used in cerebral I/R rat model, aimed to investigate the effects on cerebral infarct. The results indicated that OGD/R suppressed viability, enhanced apoptosis, which could be reversed by AS-IV treatment. Compared with the control group, the expression of p-JAK2 and p-STAT3 was significantly increased by AS-IV (60 μg/mL) under the OGD/R condition. Furthermore, AS-IV (60 μg/mL) treatment markedly increased SOD activity, whereas significantly decreased MDA activity and production of ROS in OGD/R-induced cells. The protective effects of AS-IV mentioned above were weaken or abolished while adding JAK2 inhibitor AG490. In addition, the effects of AS-IV on Janus kinase 2 and signal transducer and activator of transcription 3 (JAK2/STAT3) signaling in cerebral I/R injury were also verified in vivo. AS-IV protected against cerebral I/R injury and reversed by AG490. Therefore, in vitro and in vivo analyses suggested that AS-IV may protect against cerebral I/R injury partly mediated by JAK2/STAT3 signaling pathway and antioxidative effects. AS-IV may serve as a novel therapeutic regimen for cerebral I/R injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsApoptosisBrain IschemiaDisease Models, AnimalJanus Kinase 2MaleNeuroprotective AgentsRatsRats, Sprague-DawleyReactive Oxygen SpeciesReperfusion InjurySTAT3 Transcription FactorSaponinsSignal TransductionSuperoxide DismutaseTriterpenes

Stichwörter der Autor:innen

ApoptosisAstragaloside IVJanus kinase 2 and signal transducer and activator of transcription 3Oxygen – glucose deprivation reoxygenation

Substanzen

Neuroprotective AgentsReactive Oxygen SpeciesSTAT3 Transcription FactorSaponinsStat3 protein, ratTriterpenesastragaloside ASuperoxide DismutaseJak2 protein, ratJanus Kinase 2

Autor:innen und Institutionen

  • Department of Neurosurgery, Chinese National Petroleum Corporation Central Hospital, Langfang, China.
  • Department of Neurosurgery, Chinese National Petroleum Corporation Central Hospital, Langfang, China, weiliu353@sina.com.

Zitieren

APA

Xu, Z., Liu, W., & Huang, H. (2020). Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the Janus Kinase 2 and Signal Transducer and Activator of Transcription 3 Signaling Pathway. Pharmacology, 105(3-4), 181-189. https://doi.org/10.1159/000503361

Vancouver

Xu Z, Liu W, Huang H. Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the Janus Kinase 2 and Signal Transducer and Activator of Transcription 3 Signaling Pathway. Pharmacology. 2020;105(3-4):181-189. doi:10.1159/000503361

BibTeX
@article{Xu2020,
  author = {Xu, ZhengHu and Liu, Wei and Huang, Huai},
  title = {Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the Janus Kinase 2 and Signal Transducer and Activator of Transcription 3 Signaling Pathway},
  journal = {Pharmacology},
  year = {2020},
  volume = {105},
  number = {3-4},
  pages = {181--189},
  doi = {10.1159/000503361}
}
Kostenlos starten →